# Stereotaxis (STXS) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/STXS
## Company Profile
- Ticker: STXS
- Exchange: AMEX
- Sector: Biopharma
- Location: United States
- Tags: MedTech
## Stock Data
- Close: 1.4 USD
- Market cap: 192541299 USD
- Last updated: 2026-08-12
## Business Overview
### Endovascular Surgical Robotics
Stereotaxis develops robotic systems, instruments, and software for minimally invasive endovascular procedures.
### Magnetic Navigation
Its robotic magnetic navigation platform allows physicians to steer compatible catheters through the heart with precise remote control.
### Integrated Procedure Suite
The MAGiC robotically navigated catheter and Synchrony digital operating-room system extend Stereotaxis from capital equipment into proprietary instruments and workflow software.
### Broader Robotics Strategy
The planned Robocath acquisition would combine complementary robotic technologies across cardiac and vascular intervention.
## Why The Stock Is Moving

Following the latest company update, “Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates”, STXS closed down 4.11% at $1.40 on Aug 12, 2026. The move occurred in the trading session associated with this earnings update.

## Future Catalysts

- Stereotaxis’s catalysts are robotic catheter adoption, system placements, and growth in electrophysiology workflow. The market will care about whether the technology can keep winning procedure share.

## Recent News
- 2026-08-11 20:01 EST — [Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates](https://biopharmsignal.com/news/STXS/stereotaxis-reports-2026-second-quarter-financial-results-business-updates-5af648bf) — Source: Stereotaxis
- 2026-07-21 13:00 EST — [Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026](https://biopharmsignal.com/news/STXS/stereotaxis-to-report-second-quarter-2026-financial-results-on-august-11-2026-40f8033c) — Source: Stereotaxis
- 2026-07-20 12:31 EST — [University of Szeged Pioneers First Robotic Cardiology Program in Hungary](https://biopharmsignal.com/news/STXS/university-of-szeged-pioneers-first-robotic-cardiology-program-in-hungary-f69bf77d) — Source: Stereotaxis
- 2026-07-09 12:08 EST — [Stereotaxis Completes Acquisition of Robocath](https://biopharmsignal.com/news/STXS/stereotaxis-completes-acquisition-of-robocath-cf0c62e9) — Source: Stereotaxis
- 2026-05-12 20:06 EST — [Stereotaxis Reports 2026 First Quarter Financial Results & Business Updates](https://biopharmsignal.com/news/STXS/stereotaxis-reports-2026-first-quarter-financial-results-business-updates-369195bc) — Source: Stereotaxis